Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect? - MSN
3 days ago • Google News
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to.
3 days ago • Google News
3 weeks ago • Google News